Biomatics Capital is a Seattle-based investment organization focused on transforming healthcare through strategic investments in genomics and digital health. It targets innovative companies that aim to disrupt existing markets.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Biomatics Capital is an investment organization founded to support the transformation of healthcare and medicine through strategic investments. Based in Seattle, Washington, the organization focuses on the convergence of genomics and digital data to develop therapeutics, diagnostics, and delivery models aimed at improving patient outcomes and reducing costs in healthcare. Historically, Biomatics was an early-stage fund and active Series A lead, with a 200 million USD fund announced in 2017. The firm has a preference for outlier ideas rather than incremental improvements, backing companies with breakthrough science and strong technical founders.
Biomatics Capital invests primarily in sectors such as digital health, medical technology, gene editing, and proteomics. The organization targets companies that demonstrate innovative potential and are positioned to make substantial impacts in their respective fields. By focusing on the convergence of genomics and digital data, Biomatics aims to foster advancements that lead to better healthcare solutions.
Biomatics Capital positions itself as a hands-on partner for its portfolio companies, providing support in areas such as hiring, intellectual property, regulatory navigation, investor introductions, and exit strategies. This approach is particularly beneficial for founders in the biotech and healthcare sectors who require both scientific expertise and business development assistance.
Biomatics Capital focuses on innovative companies in the biotech and healthcare sectors, particularly those at the intersection of genomics and digital data. They target outlier companies with disruptive ideas that can enhance patient outcomes.
Founders can reach out via email at info@biomaticscapital.com. A well-prepared pitch deck that outlines the business model, market opportunity, and team is essential.
The firm invests at various stages, including seed, Series A, and Series B funding rounds, allowing them to support companies from early development through growth phases.
Biomatics Capital's unique focus on the convergence of genomics and digital data sets them apart. They prioritize investments in companies that have the potential to disrupt existing healthcare markets.
Biomatics Capital primarily invests in North America, with a strong emphasis on the United States, allowing them to tap into a rich pool of innovative healthcare startups.
Biomatics Capital provides operational support, strategic guidance, and access to their network, helping portfolio companies navigate challenges and scale effectively.
Organizations that do similar work to Biomatics Capital.
InvestorDeerfield Management is a New York City-based investment management firm specializing in healthcare investments, managing over $15 billion in assets across more than 200 companies. The firm focuses on both public and private investments in sectors such as biotechnology, medical devices, and digital health.
InvestorPolaris Partners is a multistage venture capital firm based in Boston, New York, and San Francisco, focusing on healthcare and life sciences. Founded in 1996, it has invested in over 400 companies, achieving more than 100 exits.
InvestorInvesting in the future of life sciences and technology.
InvestorAccelerating life sciences innovation in Massachusetts.
Superscout Pro
Is this page right?Reviewed · How the research works